American scientists from the Medical University of South Carolina reported that the level of serum in the serum of aminopirt Sfingosin can predict in what form the patient will transfer coronavirus infection. Research Posted in Scientific Reports magazine.
Specialists checked about 400 samples of serum blood healthy people and patients who in varying severity sorted by COVID-19. It turned out that the elevated concentrations of Sphingosin, as well as a protein, which is involved in its production, acidic ceramidase (AC) associated with asymptomatic infections. The low level of Sfingosin turned out to be a serious prerequisite for different manifestations of the disease. It also turned out that those who suffered coronavirus with symptoms, the level of Sphingosin was up to 15 times lower than in healthy.
Sphingolipid molecules are important for the integrity of the cell membrane and communications between cells. They are able to regulate inflammation and immune system in response to various infections.
According to scientists, with the help of this lipid, it is possible to determine the severity of the disease with an accuracy of 99 percent. Currently, such a study is expensive and it is impossible to carry out everywhere due to complex equipment. However, experts believe that the development of an immuno-immunimal test test is like those that are needed for the primary diagnosis of HIV, it could be a profitable and affordable alternative.
Earlier, the head of the Laboratory of Biotechnology and Virology Faculty of Natural Sciences of the Novosibirsk State University, Doctor of Biological Sciences, Professor, Corresponding Member of the Russian Academy of Sciences Sergey Neesov called the timing of the conservation of cellular immunity to COVID-19. In his opinion, after vaccination or illness, he keeps around half a year. The specialist stressed that T-cell immunity for most massive vaccines has already been investigated.